CERITINIB-FORMULIERUNG

Patent europeic · EP3148513 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3148513
Numer da la dumonda
EP15727470
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
27-05-2015
Publitgà
05-04-2017
Concedì
26-02-2020
La protecziun finescha il pli tard
26-05-2035
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
A61K 9/20 (2006.01)
A61K 9/16 (2006.01)
A61K 31/435 (2006.01)
A61K 31/506 (2006.01)
Prioritad
US 201462004359 P 29.05.2014
Dumonda PCT
PCT/IB2015/053966 27.05.2015
Publicaziun PCT
WO2015/181739 03.12.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2026

    Midada

    Published in Swissreg on 01.06.2026

  2. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  3. 02-06-2024

    Midada

    Published in Swissreg on 02.06.2024

  4. 02-06-2023

    Midada

    Published in Swissreg on 02.06.2023

  5. 26-02-2020

    Concedì

    Published in Swissreg on 26.02.2020

Partidas

Possessur

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventur

BREULLES, Sebastien

4002 Basel

ENSSLIN, Simon

4002 Basel

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.